Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot
- Conditions
- Opioid Tapering
- Registration Number
- NCT07202026
- Lead Sponsor
- Kaiser Permanente
- Brief Summary
Because of recent policies to decrease opioid use, some people using long-term opioid therapy (LTOT) are encouraged or required to stop (discontinue) taking opioids. That has led experts to be concerned that patients whose LTOT is discontinued could have untreated pain, turn to other substance use and possibly illicit opioids, or have worsened mental health symptoms leading to suicide. To guide safer policies, guidelines, and care, this study will interview patients and doctors about discontinuing LTOT and use the results to develop a patient-centered decision aid (DA) to improve patient-provider communication around discontinuation of LTOT. Once the DA is finalized, it will be pilot tested with a group of 30 patients who are currently on LTOT. The pilot will assess DA implementation feasibility; acceptability; knowledge transfer; and ability to successfully foster positive, patient-centered conversations about opioid discontinuation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Acceptability of DA 1-2 weeks We will use Matlock et al.'s acceptability ranking scale to assess the acceptability of the DA to patients
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kaiser Permanente Washington Health Research Institute
πΊπΈSeattle, Washington, United States
Kaiser Permanente Washington Health Research InstituteπΊπΈSeattle, Washington, United StatesSarah J McDonald, MPHContact833-771-0664sarah.j.mcdonald@kp.org